Where the evidence applies
The confirmed boundary, sources and reference periods — including missing data and disclosed assumptions.
Urban Nature Audit · case studies
Compare an existing council site with three nature-based options. Understand the potential council savings, wider environmental benefits and uncertainties before deciding what to investigate next.
The first release focuses on confirmed sites in England. This is professional screening, not an ecological survey, statutory biodiversity calculation or engineering design.
The existing site
A documented starting point
Three options
A consistent comparison basis
Visible limitations
What the evidence cannot tell you
No validated case-study locations have been published.
England-only appraisal scope. Generalised outline: Natural Earth. Small islands are omitted; this is not an assessment boundary or evidence of UK-wide coverage.
Real places · traceable analysis
In preparation
We will publish a location only after its actual appraisal, evidence, calculations and report have been checked. We have not yet completed that process for the five planned examples, and we are not presenting the illustrative scenarios as real site findings.
No council commission, implemented recommendation or measured outcome is claimed.
Explore the separate synthetic illustrationWhat an appraisal should make clear
The confirmed boundary, sources and reference periods — including missing data and disclosed assumptions.
The existing site and three options, with costs, potential council savings, wider benefits and revenue kept separate.
The supporting tables, uncertainty, professional limitations and further surveys or design work needed.
A decision about your site
Tell UrbanCat about your site and the options you are considering. Scope and fees are agreed in writing; the service remains under commercial-readiness review.
Urban Nature Audit is an expert-assisted screening tool. Its outputs are screening-level and non-statutory, they are intended to be operated and interpreted by a competent professional, and the product is currently under commercial-readiness review. It does not replace: